DrugDashboards
← Home
Manufacturing facility

Aurobindo Pharma Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Unit-VII, Sy No. 411/P, 425/P, 434/P, 435/P & 458/P, Plot S1 Part SEZ, TSIIC, Green Industrial Park, Polepally, Jedcherla Mandal, Mahabubnagar, Telangana 509302, India (IND)
Operations here
analysismanufacture
FDA identifiers
FEI 3007373532 · DUNS 650381903

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2022-05-10
  • OAIDrug Quality Assurance2019-09-27
  • NAIDrug Quality Assurance2017-06-24
  • NAIDrug Quality Assurance2015-03-13
  • NAIDrug Quality Assurance2012-06-19
  • VAIDrug Quality Assurance2010-07-30
  • NAIDrug Quality Assurance2009-10-13

Drugs this plant is listed as making

140 distinct drugs across 450 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.